Integrated systems may have economic incentive for using alteplase in stroke patients.
D000208:Acute Disease; D002545:Brain Ischemia / Q000188:drug therapy* / Q000191:economics; D003362:Cost-Benefit Analysis; D019033:Delivery of Health Care, Integrated / Q000191:economics; D006801:Humans; D017063:Outcome Assessment, Health Care / Q000191:economics*; D010960:Plasminogen Activators / Q000191:economics* / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000191:economics* / Q000627:therapeutic use
D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator